raloxifene hydrochloride has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Minamino, T; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
| Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
2 other study(ies) available for raloxifene hydrochloride and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Raloxifene improves coronary perfusion, cardiac contractility, and myocardial metabolism in the ischemic heart: role of phosphatidylinositol 3-kinase/Akt pathway.
Topics: Animals; Dogs; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Raloxifene Hydrochloride; Signal Transduction | 2004 |
[Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart].
Topics: Animals; Dogs; Estradiol; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |